Company patents
GALVANI BIOELECTRONICS LIMITED
GALVANI BIOELECTRONICS LIMITED's patent strategy reveals a surprising and significant shift away from its core focus, with its dominant Electrotherapy / Radiation Therapy category, representing 86.8% of its portfolio, experiencing a sharp decline of 45.2% in 2024 and a further 17.6% in 2025. This trend is mirrored in Medical Diagnostics & Surgery and Pharmaceutical Preparations, indicating a broad de-prioritization across its traditional medical device and pharma biotech sectors, with only a minor, stable interest in Plastics Shaping & Molding emerging with 1 patent in 2025 and 1 so far in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
76 US filings (since 2023) · 4 categories · 5 themes
Therapeutic application of electrical signals to nerves or tissues to modulate their activity, often using implantable devices, electrodes, and sophisticated programming for various conditions.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Systems that provide therapeutic stimulation or field therapy through wearable devices, often incorporating physiological sensing and closed-loop feedback for personalized and adaptive treatment.
Use of alternating electric or magnetic fields at specific frequencies and intensities to achieve therapeutic effects, such as inhibiting cell proliferation (e.g., cancer) or modulating cytokine production.
Development of devices and methods for non-invasive or minimally invasive collection and analysis of physiological data, often from wearable sensors, to monitor health, activity, or specific conditions.
Patents
Showing 1-10 of 138